Mizuho lowered the firm’s price target on Erasca (ERAS) to $26 from $28 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ERAS:
- Analyst Reiterates Buy on ERAS-0015’s Emerging Pan-RAS Potential; $20 Price Target Maintained
- Erasca reports Q1 EPS (60c), consensus (23c)
- Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
- Erasca enters AURORAS-1 clinical trial pact, supply agreement with Merck
- Erasca recent share selloff overdone, says JPMorgan